<html><body><table border="1"><tr bgcolor="#9acd32"><th align="left">Class</th><th align="left">Attribute</th><th align="left">Definition</th></tr><tr><td>EARootClass</td><td>0 attribute(s)</td><td></td></tr><tr><td>Participant</td><td>5 attribute(s)</td><td>A human being who may be assigned to a study. The study specifies how the subjectâ€™s illness will be treated and/or monitored overtime.</td></tr><tr><td>Participant</td><td>administrativeGenderCode</td><td>The text that describes the assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female within a person.</td></tr><tr><td>Participant</td><td>birthDate</td><td>The month, day and year on which the person was born.</td></tr><tr><td>Participant</td><td>ethnicGoupCode</td><td>The person's self declared ethnic origination, independent of racial origination. For example, for the NCI, these ethnic groups are based on OMB approved categories.</td></tr><tr><td>Participant</td><td>maritalStatusCode</td><td>Commonly used category name to describe the marital status of a person. Values include: Married, Widowed, Single, Separated, etc.</td></tr><tr><td>Participant</td><td>raceCode</td><td>A value representing a person's self declared racial origination, independent of ethnic origination. For example, for the NCI, this code is based on OMB approved categories.</td></tr><tr><td>EmailBasedRecipient</td><td>1 attribute(s)</td><td>An email used to notify accruals.</td></tr><tr><td>EmailBasedRecipient</td><td>emailAddress</td><td>An email used to notify accruals.</td></tr><tr><td>BookRandomization</td><td>0 attribute(s)</td><td>A method of assigning patients to treatment arms based on a pre-determined list and the order in which they accrue on the trial.</td></tr><tr><td>StudyInvestigator</td><td>7 attribute(s)</td><td>Specifies the information describing an investigator associated with a study, i.e. role, association start and end date, etc.</td></tr><tr><td>StudyInvestigator</td><td>endDate</td><td>The date when an investigator ends participation in a study.</td></tr><tr><td>StudyInvestigator</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StudyInvestigator</td><td>roleCode</td><td>The role a site plays on a study (e.g. primary investigator)</td></tr><tr><td>StudyInvestigator</td><td>signatureIndicator</td><td>[Additional Documentation] A code specifying whether and how the participant has attested his participation through a signature and or whether such a signature is needed. [BRIDG] [End Documentation] The indicator representing that the investigator has signed the document.[DCP]</td></tr><tr><td>StudyInvestigator</td><td>signatureText</td><td>[Additional Documentation] A textual or multimedia depiction of the signature by which the participant endorses his or her participation in the Act as specified in the Participation.typeCode and that he or she agrees to assume the associated accountability. [BRIDG] [End Documentation] The signed name of the investigator who is responsible for completing a form or report for a clinical trial. [CTEP]</td></tr><tr><td>StudyInvestigator</td><td>startDate</td><td>The date when an investigator begins participation in a study.</td></tr><tr><td>StudyInvestigator</td><td>statusCode</td><td>An indication of whether an investigator is currently participating in a study</td></tr><tr><td>ScheduledNonTreatmentEpoch</td><td>0 attribute(s)</td><td>Description of participant/subject relationship with a non-treatment epoch</td></tr><tr><td>StudyOrganization</td><td>0 attribute(s)</td><td>Any organization that would be involved, generally the lead or coordinating group, but others can be involved in the trial.</td></tr><tr><td>ExclusionEligibilityCriteria</td><td>0 attribute(s)</td><td>Requirements that, if met, will exclude the subject from participation in a clinical trial.</td></tr><tr><td>Randomization</td><td>1 attribute(s)</td><td>Allocation of subject to groups, e.g., for experimental and control regimens.</td></tr><tr><td>Randomization</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Study</td><td>14 attribute(s)</td><td>[Additional Documentation] A systematic evaluation of an observation or an intervention (for example, treatment, drug, device, procedure or system) in one or more subjects. Frequently this is a test of a particular hypothesis about the treatment, drug, device, procedure or system. [CDAM]  A study can be either primary or correlative. A study is considered a primary study if it has one or more correlative studies. A correlative study extends the objectives or observations of a primary study, enrolling the same, or a subset of the same, subjects as the primary study. A Clinical Trial is a Study with type= "intervention" with subjects of type="human". [BRIDG] [End Documentation]</td></tr><tr><td>Study</td><td>blindedIndicator</td><td>Indicator of Yes (Y) or No (N) to specify if a protocol is blinded.</td></tr><tr><td>Study</td><td>descriptionText</td><td>The free text field of the type of study being conducted. [CTEP]</td></tr><tr><td>Study</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Study</td><td>longTitleText</td><td>Descriptive text used to represent the long title or name of a protocol.</td></tr><tr><td>Study</td><td>multiInstitutionIndicator</td><td>A Yes/No response to indicate if a protocol is being conducted at more than one site concurrently.</td></tr><tr><td>Study</td><td>nciIdentifier</td><td>The numeric or alphanumeric identification assigned to the study by the NCI. Inter-Group protocols should use the lead Groups protocol number.</td></tr><tr><td>Study</td><td>phaseCode</td><td>Values include: I, I/II, II, III, NA. Coded designation of phase (I, II, III, or IV) for a clinical trial. </td></tr><tr><td>Study</td><td>precisText</td><td>A structured summary description of a protocol document.</td></tr><tr><td>Study</td><td>randomizedIndicator</td><td>An indicator as to whether a study is randomized.</td></tr><tr><td>Study</td><td>shortTitleText</td><td>[Additional Documentation] A name or abbreviated title by which the document is known. [BRIDG] [End Documentation] Title of a protocol limited to 30 characters in length.</td></tr><tr><td>Study</td><td>sponsorCode</td><td>Values include: AB-Abbott Labs, AL-Alkermes, Inc., APH- Angiotech, AM- Amgen, etc. Code used to identify the sponsor (IND holder) for a clinical trial.</td></tr><tr><td>Study</td><td>status</td><td>The current stage in the life cycle of the study (development, active, closed to accrual, closed to accrual tretment continues, withdrawn, complete, etc)</td></tr><tr><td>Study</td><td>targetAccrualNumber</td><td>Total number of patients/subjects/participants needed for protocol enrollment (accrual). </td></tr><tr><td>Study</td><td>type</td><td>Studies are characterize as treatment or non-treatment studies. Non-treatment studies can be further classified and laboratory, cancer control, economic, phycho-oncology, retrospective analysis, survey or tissue bank.</td></tr><tr><td>StratificationCriterionPermissibleAnswer</td><td>2 attribute(s)</td><td>The answers from which the subject can choose</td></tr><tr><td>StratificationCriterionPermissibleAnswer</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StratificationCriterionPermissibleAnswer</td><td>permissibleAnswer</td><td>The answers from which the subject can choose</td></tr><tr><td>Investigator</td><td>1 attribute(s)</td><td>A researcher in a clinical trial or clinical study who oversees all aspects of the trial, #NOTES#such as concept development, protocol writing, protocol submission for IRB approval, participant recruitment, informed consent, data collection, analysis, interpretation and presentation.</td></tr><tr><td>Investigator</td><td>nciIdentifier</td><td>The identifier assigned in the NCI investigator registry to a physician approved for conducting a clinical trial. [CTEP]</td></tr><tr><td>CalloutRandomization</td><td>0 attribute(s)</td><td>A method of randomly assigning patients to treatment arms by contacting the statistician for the next protocol treatment arm.</td></tr><tr><td>StratificationCriterionAnswerCombination</td><td>0 attribute(s)</td><td>The ordered list of stratification criteria answers.</td></tr><tr><td>DiseaseHistory</td><td>2 attribute(s)</td><td>The medical history of a person's diseases.</td></tr><tr><td>DiseaseHistory</td><td>otherPrimaryDiseaseCode</td><td>The code which represents a type of disease other than the primary disease for which the patient is being treated.</td></tr><tr><td>DiseaseHistory</td><td>otherPrimaryDiseaseSiteCode</td><td>The code which represents a site of disease other than the primary disease for which the patient is being treated.</td></tr><tr><td>Notification</td><td>1 attribute(s)</td><td>Identifies individuals and threshholds for notifying by email when accruals are met.</td></tr><tr><td>Notification</td><td>threshold</td><td>The portion of accrual to be met for notification of accrual to a study.</td></tr><tr><td>StudySite</td><td>7 attribute(s)</td><td>A health care site in which clinical trial activities are conducted.</td></tr><tr><td>StudySite</td><td>endDate</td><td>The date when a site ends participation in a study.</td></tr><tr><td>StudySite</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StudySite</td><td>irbApprovalDate</td><td>The date the institutional review board or research ethics board authorized approval or reapproval of the study protocol. </td></tr><tr><td>StudySite</td><td>roleCode</td><td>The role a site plays on a study (e.g. coordinating or affiliate)</td></tr><tr><td>StudySite</td><td>siteStudyStatus</td><td>An indication of whether a site is currently participating in a study</td></tr><tr><td>StudySite</td><td>startdate</td><td>The date when a site begins participation in a study.</td></tr><tr><td>StudySite</td><td>targetAccrualNumber</td><td>Total number of patients/subjects/participants needed for protocol enrollment at this site.</td></tr><tr><td>Person</td><td>4 attribute(s)</td><td>A human being.</td></tr><tr><td>Person</td><td>firstName</td><td>A word or group of words indicating a person's first (personal or given) name; the name that precedes the surname. Synonym = Given Name. [DCP]</td></tr><tr><td>Person</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Person</td><td>lastName</td><td>A means of uniquely identifying an individual by using a word or group of words indicating a person's last (family) name. Last Name, Surname. [DCP]</td></tr><tr><td>Person</td><td>maidenName</td><td>Last name of family of origin</td></tr><tr><td>Arm</td><td>4 attribute(s)</td><td>A specific treatment protocol and/or intervention used in a clinical trial. #NOTES#A planned subject path through the study, described by a sequence of Elements. The group of subjects assigned to an Arm is typically equivalent to a treatment group. For example, a study could have 3 Arms named Placebo, Treatment A, and Treatment B. Each of those arms could include 3 Epochs -- screening, intervention, and follow-up. The screening Epoch may be identical for all three arms, but the intervention Epoch would have different activities for placebo, treatment A, and treatment B.</td></tr><tr><td>Arm</td><td>accrualCeiling</td><td>Total number of patients targeted for accrual to an arm of a treatment protocol.</td></tr><tr><td>Arm</td><td>descriptionText</td><td>The full description of the details of a protocol treatment arm or group.</td></tr><tr><td>Arm</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Arm</td><td>name</td><td>The descriptive name or number of the protocol treatment arm or group.</td></tr><tr><td>StudyDisease</td><td>1 attribute(s)</td><td>One of the diseases identified when registering a subject to a study.</td></tr><tr><td>StudyDisease</td><td>leadDisease</td><td>An indicator that the StudyDisease is the primary disease assigned when a subject is registered to a study.</td></tr><tr><td>StudyAmendment</td><td>3 attribute(s)</td><td>Protocols require modification during the life cycle of the study.  Amendments vary in severity from correcting spelling errors to  requiring that subject accrual be stopped until the amendment recieves IRB approval.</td></tr><tr><td>StudyAmendment</td><td>amendmentDate</td><td>The date that the institution's IRB approved the amendment.</td></tr><tr><td>StudyAmendment</td><td>amendmentVersion</td><td>A free text field to be used by the institution to help them identify the study amendments.</td></tr><tr><td>StudyAmendment</td><td>comments</td><td>A free text field for entering notes explaining the purpose of the amendment </td></tr><tr><td>Identifier</td><td>5 attribute(s)</td><td>a coded value that represents an object or concept (example, participant or study)</td></tr><tr><td>Identifier</td><td>id</td><td>an ID code assigned to the identifier</td></tr><tr><td>Identifier</td><td>isPrimary</td><td>boolean indicator whether it is the authoritative (and presumedly unique identifier assigned by the controlling body over that object</td></tr><tr><td>Identifier</td><td>source</td><td>the source organization that assigned the identifier</td></tr><tr><td>Identifier</td><td>type</td><td>a description of the identifier type (example: medical record number, irb code, etc)</td></tr><tr><td>Identifier</td><td>value</td><td>the actual identifer number or text</td></tr><tr><td>ResearchStaff</td><td>0 attribute(s)</td><td>Individuals involved in the conduct of a study.</td></tr><tr><td>InvestigatorGroup</td><td>5 attribute(s)</td><td>A list of investigators used for bulk assignment of investigators to studies.</td></tr><tr><td>InvestigatorGroup</td><td>descriptionText</td><td>The textual description of a group of investigators.</td></tr><tr><td>InvestigatorGroup</td><td>endDate</td><td>The date when an investigators participation in a specific group ends.</td></tr><tr><td>InvestigatorGroup</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>InvestigatorGroup</td><td>name</td><td>The textual name of a group of investigators</td></tr><tr><td>InvestigatorGroup</td><td>startDate</td><td>The date when an investigators participation in a specific group begins.</td></tr><tr><td>Epoch</td><td>5 attribute(s)</td><td>Used to describe a period of time that cuts across the arms of a study. Assuming time is depicted horizontally, an Epoch is a vertical segmentation of one or more arms which are parallel in time. Epochs typically group similar activities.#NOTES#Used to describe a period of time that cuts across the arms of a study. Assuming time is depicted horizontally, an Epoch is a vertical segmentation of one or more arms which are parallel in time. Epochs typically group similar activities (i.e. screening, treatment, follow-up). Participants in a study move through epochs serially over time, and no participant can be assigned to more than one epoch at any particular time. For example, an Epoch could be called "Screening", "Treatment", or "Follow Up".</td></tr><tr><td>Epoch</td><td>consentIndicator</td><td>Used to indicate whether a (new) consent needs to be signed to enter a specifed epoch</td></tr><tr><td>Epoch</td><td>descriptionText</td><td>A text description of the epoch</td></tr><tr><td>Epoch</td><td>epochOrder</td><td>Used to describe a period of time that cuts across the arms of a study. Assuming time is depicted horizontally, an Epoch is a vertical segmentation of one or more arms which are parallel in time. </td></tr><tr><td>Epoch</td><td>id</td><td>A coded value representing the epoch</td></tr><tr><td>Epoch</td><td>name</td><td>A coded value which indicates the general scope of the activities that occur in the various arms of the Epoch. For example, screening, treatment, follow-up, etc.</td></tr><tr><td>StratificationCriterion</td><td>3 attribute(s)</td><td>Defining stratification criterion for a study allows the affect of different demographics in the subject population to be evaluated.  A study may have  zero to many stratification criterion defined. #NOTES#Defining stratification criterion for a study allows the affect of different demographics in the subject population to be evaluated.  A study may have  zero to many stratification criterion defined. Subjects are placed in different stratum groups based on their response to the stratification questions.</td></tr><tr><td>StratificationCriterion</td><td>displayNumber</td><td>The index of the stratification critierion to be shown to a user.</td></tr><tr><td>StratificationCriterion</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StratificationCriterion</td><td>questionText</td><td>The specific question to be answered in order to identify the the stratum group for the study subject.</td></tr><tr><td>HealthcareSiteInvestigator</td><td>3 attribute(s)</td><td>A researcher in a clinical trial or clinical study who oversees operational aspects of the trial at a specific health care site</td></tr><tr><td>HealthcareSiteInvestigator</td><td>id</td><td>A coded value that represents a health care site investigator</td></tr><tr><td>HealthcareSiteInvestigator</td><td>statusCode</td><td>A coded value that represents the activity status of the studysite investigator, that will grant that investigator activity capability within that site context. expected values of acitve/inactive</td></tr><tr><td>HealthcareSiteInvestigator</td><td>statusDate</td><td>The date which the current activity status was assigned</td></tr><tr><td>PhoneCallRandomization</td><td>0 attribute(s)</td><td>A type of randomization of subjects to a study where a registrar calls the individual responsible for assigning arms.</td></tr><tr><td>Address</td><td>6 attribute(s)</td><td>A standardized representation of the geographical location of a person, business, building, or organization.</td></tr><tr><td>Address</td><td>city</td><td>A component of an address that specifies a location by identification of a city, town, or village.</td></tr><tr><td>Address</td><td>countryCode</td><td>A component of an address that specifies a location by identification of a country.</td></tr><tr><td>Address</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Address</td><td>postalCode</td><td>The string of characters used to identify the five-digit Zone Improvement Plan (ZIP) code and the four-digit extension code (if available) that represents the geographic segment that is a subunit of the ZIPcode, assigned by the U.S. Postal Service.</td></tr><tr><td>Address</td><td>stateCode</td><td>A component of an address that specifies a location by identification of the primary governmental administrative subdivision. </td></tr><tr><td>Address</td><td>streetAddress</td><td>A component of an address that specifies a location by identification of an assigned numeral or string of numerals and characters and a named street/thoroughfare.</td></tr><tr><td>ContactMechanism</td><td>2 attribute(s)</td><td>A method of contacting a person to communicate or receive information.</td></tr><tr><td>ContactMechanism</td><td>type</td><td>A type of method of contacting a person, such as by phone, mail, email or in person.</td></tr><tr><td>ContactMechanism</td><td>value</td><td>The specific method used to contact a person.</td></tr><tr><td>StudyCoordinatingCenter</td><td>0 attribute(s)</td><td>The organization that is coordinating the study in a multi-study setting.  In a local setting, it is the treating organization.</td></tr><tr><td>BookRandomizationEntry</td><td>2 attribute(s)</td><td>An item/element of a randomization book that can be used to link a patient study number with a protocol treatment arm.</td></tr><tr><td>BookRandomizationEntry</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>BookRandomizationEntry</td><td>position</td><td>The numerical position of a specific randomization entry in the randomization book</td></tr><tr><td>SubjectStratificationAnswer</td><td>0 attribute(s)</td><td>An answer to a stratification question for a study subject on a scheduled treatment epoch.</td></tr><tr><td>DiseaseCategory</td><td>1 attribute(s)</td><td>A specific classification of the types of diseases.</td></tr><tr><td>DiseaseCategory</td><td>name</td><td>The name of a disease category.</td></tr><tr><td>SiteInvestigatorGroupAffiliation</td><td>3 attribute(s)</td><td>A list of investigators at a site used for bulk assignment of investigators to studies.</td></tr><tr><td>SiteInvestigatorGroupAffiliation</td><td>endDate</td><td>The date when an investigators participation in a specific group at a site ends.</td></tr><tr><td>SiteInvestigatorGroupAffiliation</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>SiteInvestigatorGroupAffiliation</td><td>startDate</td><td>The date when an investigators participation in a specific group at a site begins.</td></tr><tr><td>TreatmentEpoch</td><td>1 attribute(s)</td><td>A cross-cutting period of time in the study whereby the subject is being treated.  TreatmentEpochs can have eligibility criteria, stratification, and randomization while NonTreatmentEpochs do not.</td></tr><tr><td>TreatmentEpoch</td><td>randomizedIndicator</td><td>Whether the cross-cutting period of time in the study requires that subjects be randomized onto the study.</td></tr><tr><td>StudySubject</td><td>12 attribute(s)</td><td>Specifies the information associated with assigning a Subject to a Study. Examples include: the date a subject was on, and off, the study; study arm assignment; etc.</td></tr><tr><td>StudySubject</td><td>compassionateIndicator</td><td>An indicator that identifies whether the subject has been registered onto the study for compassionate treatment, which may indicate that the subject should not be counted in accruals and analysis.</td></tr><tr><td>StudySubject</td><td>eligibilityIndicator</td><td>Whether the subject is eligble to be registered to the study.  All inclusion criteria must be answered "Yes" or "Not Applicable" and all exclusion criteria must be answered "No" or "Not Applicable".</td></tr><tr><td>StudySubject</td><td>eligibilityWaiverReasonText</td><td>The reason that a subject is given a sponsor-approved waiver for meeting protocol-defined eligibility requirements.</td></tr><tr><td>StudySubject</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StudySubject</td><td>informedConsentFormSignedDate</td><td>The date the patient acknowledged participation on the protocol by signing the informed consent document.</td></tr><tr><td>StudySubject</td><td>informedConsentVersion</td><td>The version of the consent document that the subject signed.</td></tr><tr><td>StudySubject</td><td>offStudyDate</td><td>The date when the patient is removed from the protocol, i.e., is not being followed and will not be retreated.</td></tr><tr><td>StudySubject</td><td>offStudyReasonText</td><td>Text explanation for patient/participant coming off a clinical trial with reason of 'Other'. </td></tr><tr><td>StudySubject</td><td>startDate</td><td>Treatment start date</td></tr><tr><td>StudySubject</td><td>stratumGroupNumber</td><td>An index identifying the stratum group that the study subject has been assigned.</td></tr><tr><td>StudySubject</td><td>studyParticipantIdentifier</td><td>The unique number assigned to identify a patient on a protocol.</td></tr><tr><td>StudySubject</td><td>treatingPhysician</td><td>Medical doctor who enrolls a patient</td></tr><tr><td>ScheduledArm</td><td>5 attribute(s)</td><td>Current study path of participant/subject</td></tr><tr><td>ScheduledArm</td><td>eligibilityIndicator</td><td>Code for describing study elgibility status.  Participant meets or does not meet the study eligibility criteria.</td></tr><tr><td>ScheduledArm</td><td>eligibilityWaiverReason</td><td>Reason a study eligibility waiver is granted</td></tr><tr><td>ScheduledArm</td><td>id</td><td>Identifier for a study path</td></tr><tr><td>ScheduledArm</td><td>kitNumber</td><td>A value that links the study subject to a specific blinded treatment.</td></tr><tr><td>ScheduledArm</td><td>startDate</td><td>Month, day, and year a participant/subject starts a study path</td></tr><tr><td>StudyFundingSponsor</td><td>0 attribute(s)</td><td>The organization that is funding the study.</td></tr><tr><td>StratumGroup</td><td>3 attribute(s)</td><td>All combinations of stratification criteria answers make up the list of stratum groups, which is used to assign subjects to arms on a study.</td></tr><tr><td>StratumGroup</td><td>currentPosition</td><td>An index representing the ordered position of a stratum group in the list of all stratum groups for display to users.</td></tr><tr><td>StratumGroup</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>StratumGroup</td><td>stratumGroupNumber</td><td>The stratum group to which the subject is assigned based on their response to the stratification questions.</td></tr><tr><td>SubjectEligibilityAnswer</td><td>2 attribute(s)</td><td>Participant specific response to, and identification of that response, to study eligibility criteria</td></tr><tr><td>SubjectEligibilityAnswer</td><td>answerText</td><td>Participant specific response to study eligibility criteria</td></tr><tr><td>SubjectEligibilityAnswer</td><td>id</td><td>Identifier for the participant specific answer text</td></tr><tr><td>FundingSponsor</td><td>0 attribute(s)</td><td>A group or organization supplying some funding for the operation, (but not necessarily managing the trial).</td></tr><tr><td>NonTreatmentEpoch</td><td>4 attribute(s)</td><td>An epoch where no treatment activity occurs (example followup)</td></tr><tr><td>NonTreatmentEpoch</td><td>accrualCeiling</td><td>The maximum number of participants allowed or expected to participate in the epoch.</td></tr><tr><td>NonTreatmentEpoch</td><td>accrualIndicator</td><td>An indicator whether the entry into the epoch counts as an accrual (applies only to pre-treatment, epochs where participation is not certain)</td></tr><tr><td>NonTreatmentEpoch</td><td>enrollmentIndicator</td><td>An indicator whether entry into the epoch requires enrollment</td></tr><tr><td>NonTreatmentEpoch</td><td>reservationIndicator</td><td>An indicator whether a reservation for a position in the epoch can be made</td></tr><tr><td>ScheduledEpoch</td><td>2 attribute(s)</td><td>Description of a participant/subject's current study epoch</td></tr><tr><td>ScheduledEpoch</td><td>registrationStatus</td><td>Status of a participant/subject's epoch registration</td></tr><tr><td>ScheduledEpoch</td><td>startDate</td><td>Month, day, year a participant/subject starts on a specific epoch</td></tr><tr><td>StudyPersonnel</td><td>4 attribute(s)</td><td>Individuals involved in the conduct of a study.</td></tr><tr><td>StudyPersonnel</td><td>endDate</td><td>The date when a study personnel ends participation in a study.</td></tr><tr><td>StudyPersonnel</td><td>roleCode</td><td>The role a study personell plays on a study (e.g. registrar or study coordinator)</td></tr><tr><td>StudyPersonnel</td><td>startDate</td><td>The date when a study personnel begins participation in a study.</td></tr><tr><td>StudyPersonnel</td><td>statusCode</td><td>An indication of whether a study personnel is currently participating in a study</td></tr><tr><td>InclusionEligibilityCriteria</td><td>0 attribute(s)</td><td>Requirements that, if met, determine the subject is eligible to participate in a clinical trial.</td></tr><tr><td>DiseaseTerm</td><td>3 attribute(s)</td><td>A specific human disease.</td></tr><tr><td>DiseaseTerm</td><td>ctepTerm</td><td>The name used by CTEP for a specific disease.</td></tr><tr><td>DiseaseTerm</td><td>medraCode</td><td>The corresponding MEDRA code for a specific disease.</td></tr><tr><td>DiseaseTerm</td><td>term</td><td>The name or terminology used to identify a specific disease.</td></tr><tr><td>RoleBasedRecipient</td><td>1 attribute(s)</td><td>The role on a study used to identify individuals for notification of accruals.</td></tr><tr><td>RoleBasedRecipient</td><td>role</td><td>The role on a study used to identify individuals for notification of accruals.</td></tr><tr><td>EligibilityCriteria</td><td>4 attribute(s)</td><td>Requirements that must be met for subjects to be included in a study. These requirements ensure that subjects on a study are similar to each other in terms of specific factors such as age, type and stage of cancer, general health and treatment history.</td></tr><tr><td>EligibilityCriteria</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>EligibilityCriteria</td><td>notApplicableIndicator</td><td>A yes/no indicator that specifies whether or not the specific eligiability criteria is not applicable to this participant.</td></tr><tr><td>EligibilityCriteria</td><td>questionNumber</td><td>Sequence or position of a component in a list of question or data items. </td></tr><tr><td>EligibilityCriteria</td><td>questionText</td><td>The complete text of an individual question/criterion on the eligibility checklist of a protocol.</td></tr><tr><td>AnatomicSite</td><td>2 attribute(s)</td><td>Named locations of or within the body.</td></tr><tr><td>AnatomicSite</td><td>category</td><td>Text name of a major body organ system.</td></tr><tr><td>AnatomicSite</td><td>name</td><td>Text name of a specific anatomic organ site (single) within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation.</td></tr><tr><td>Organization</td><td>4 attribute(s)</td><td>A formalized group of persons or other organizations collected together for a common purpose (such as administrative, legal, political) and the infrastructure to carry out that purpose.</td></tr><tr><td>Organization</td><td>descriptionText</td><td>Text describing the organization.</td></tr><tr><td>Organization</td><td>id</td><td>The system generated unique identifier.</td></tr><tr><td>Organization</td><td>name</td><td>Name of the organization or an institution conducting the trial. [DCP]</td></tr><tr><td>Organization</td><td>nciInstituteCode</td><td>A NCI assigned code that uniquely identifies an organization</td></tr><tr><td>ScheduledTreatmentEpoch</td><td>2 attribute(s)</td><td>Description of participant/subject relationship with a treatment epoch</td></tr><tr><td>ScheduledTreatmentEpoch</td><td>eligibilityIndicator</td><td>Indicates participant/subject eligibility on this treatment epoch</td></tr><tr><td>ScheduledTreatmentEpoch</td><td>eligibilityWaiverResonText</td><td>Text describing why a participant/subject epoch ineligibility was waived</td></tr></table></body></html>